nitroflurbiprofen has been researched along with flurbiprofen in 56 studies
Studies (nitroflurbiprofen) | Trials (nitroflurbiprofen) | Recent Studies (post-2010) (nitroflurbiprofen) | Studies (flurbiprofen) | Trials (flurbiprofen) | Recent Studies (post-2010) (flurbiprofen) |
---|---|---|---|---|---|
58 | 1 | 6 | 2,072 | 466 | 575 |
Protein | Taxonomy | nitroflurbiprofen (IC50) | flurbiprofen (IC50) |
---|---|---|---|
Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.1683 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.6754 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.574 | |
Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 1.56 | |
Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 0.5 | |
Solute carrier family 22 member 6 | Homo sapiens (human) | 1.5 | |
Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 0.17 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (17.86) | 18.2507 |
2000's | 38 (67.86) | 29.6817 |
2010's | 8 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdul-Hay, S; Qin, Z; Schiefer, IT; Thatcher, GR; Vanni, M; Wang, H | 1 |
Baydoun, AR; Cicala, C; Cirino, G; Mancuso, F; Wallace, JL | 1 |
Adami, A; Benoni, G; Cuzzolin, L; Del Soldato, P; Mariotto, S; Suzuki, H | 1 |
Cicala, C; Cirino, G; Grisham, MB; McKnight, W; Reuter, B; Wallace, JL | 1 |
Adami, A; Benoni, G; Carcereri de Prati, A; Cuzzolin, L; Mariotto, S; Menegazzi, M; Suzuki, H | 1 |
Del Soldato, P; di Giamberardino, M; Padovano, R; Panara, MR; Patrignani, P; Rotondo, MT; Santini, G; Sciulli, MG | 1 |
Bjarnason, I; Jacob, M; Macpherson, A; Mahmud, T; Price, AB; Rafi, S; Scott, D; Sherwood, R; Sigthorsson, G; Somasundaram, S; Wrigglesworth, JM | 1 |
De Nucci, G; Donato, JL; Fujihara, CK; Malheiros, DM; Poli, A; Zatz, R | 1 |
Hofer, M; Juchelková, L; Pipalová, I; Pospísil, M | 1 |
Bertrand, V; Chaussade, S; Chauvelot-Moachon, L; Couturier, D; Giroud, JP; Guimbaud, R; Lamrani, A; Mauprivez, C; Sogni, P | 1 |
Antonelli, E; Cirino, G; Coata, G; Distrutti, E; Federici, B; Fiorucci, S; Morelli, A; Morelli, O; Renzo, GD; Santucci, L; Soldato, PD | 1 |
Hanson, PJ; Johal, K | 1 |
Bertrand, V; Del Soldato, P; Lebrec, D; Lefilliatre, P; Moreau, R; Pateron, D; Sogni, P | 1 |
Al-Swayeh, OA; Keeble, J; Moore, PK | 1 |
Buchwald, SL; Moradi, WA | 1 |
Armour, KE; Armour, KJ; Del Soldato, P; Ralston, SH; Torbergsen, AC; van 't Hof, RJ | 1 |
Ajmone-Cat, MA; Minghetti, L; Nicolini, A | 1 |
Cirino, G; del Soldato, P; Ialenti, A; Ianaro, A; Lippolis, L; Maffia, P; Maiello, FM; Sorrentino, R | 1 |
Aldini, G; Carini, M; Facino, RM; Orioli, M; Wenk, GL | 1 |
del Soldato, P; Ma, L; Wallace, JL | 1 |
Hauss-Wegrzyniak, B; McGann, K; Rosi, S; Wenk, GL | 2 |
Appleyard, RC; Del Soldato, P; Murrell, GA; Wang, MX; Wei, AQ; Yuan, J | 1 |
Marshall, M; Moore, PK | 1 |
Beckman, M | 1 |
de Nucci, G; Fujihara, CK; Gonçalves, AR; Malheiros, DM; Mattar, AL; Noronha, Ide L; Zatz, R | 1 |
Bergami, A; Brambilla, E; Butti, E; Comi, G; Furlan, R; Gasparini, L; Kurne, A; Martino, G; Maucci, R; Ongini, E | 1 |
Butcher, C; Evans, CE | 1 |
Scatena, R | 1 |
Del Soldato, P; Idris, AI; Ralston, SH; van't Hof, RJ | 1 |
Benjamin, N; Del Soldato, P; Donnellan, C; Forte, P; Johnston, A; O'Byrne, S; Vojnovic, I; Zacharowski, K; Zacharowski, P | 1 |
Breese, E; Del Soldato, P; Mitchell, J; Warner, T; Wood, E; Zacharowski, P | 1 |
Ajmone-Cat, MA; Bernardo, A; Gasparini, L; Minghetti, L; Ongini, E | 1 |
Kadish, I; van Groen, T | 1 |
Gasparini, L; Morgan, D; Ongini, E; Wilcock, D | 1 |
Bhatia, M; Huang, J; Moochhala, SM; Moore, PK | 1 |
Casagrande, S; Chiroli, V; Govoni, M; Maucci, R; Tocchetti, P | 1 |
Anuar, F; Bhatia, M; Kwong, SE; Moore, PK; Siau, JL; Whiteman, M | 1 |
Anuar, F; Bhatia, M; Moore, PK; Whiteman, M | 1 |
Bottinelli, R; Brunelli, S; Clementi, E; Cossu, G; Covarello, D; D'Antona, G; Galvez, BG; Innocenzi, A; Monopoli, A; Ongini, E; Perrotta, C; Sanvito, F; Sciorati, C | 1 |
Fevery, J; Laleman, W; Nevens, F; Van der Elst, I; Van Landeghem, L; Zeegers, M | 1 |
Cilurzo, F; Minghetti, P; Montanari, L; Selmin, F; Vistoli, G | 1 |
Astle, CM; Floyd, RA; Flurkey, K; Harrison, DE; Hensley, KL; Javors, MA; Leeuwenburgh, C; Miller, RA; Nadon, NL; Nelson, JF; Ongini, E; Strong, R; Warner, HR | 2 |
Ji, H; Peng, SX; Zhang, YH | 1 |
Idris, AI; Ralston, SH; van't Hof, RJ | 1 |
Kedia, GT; Kuczyk, MA; Neumayer, E; Scheller, F; Uckert, S | 1 |
Abdul-Hay, SO; Ashghodom, RT; Luo, J; Thatcher, GR | 1 |
Abdul-Hay, SO; Edirisinghe, P; Thatcher, GR | 1 |
Astle, CM; Flurkey, K; Harrison, DE | 1 |
Caniglia, S; Impagnatiello, F; L'Episcopo, F; Marchetti, B; Morale, MC; Serra, PA; Testa, N; Tirolo, C | 1 |
Kadish, I; Miettinen, P; van Groen, T | 1 |
Caniglia, S; Impagnatiello, F; L'episcopo, F; Marchetti, B; Morale, MC; Testa, N; Tirolo, C | 1 |
Ishiguro, T; Izumiya, M; Midorikawa, Y; Nakagama, H; Ohata, H; Okamoto, K; Sakai, H; Sato, A; Tsuchiya, N | 1 |
De Nardi, C; Monopoli, A; Ongini, E; Thomas, GD; Victor, RG; Ye, J | 1 |
Govoni, M; Lundberg, JO; Tocchetti, P | 1 |
3 review(s) available for nitroflurbiprofen and flurbiprofen
Article | Year |
---|---|
Nitroflurbiprofen (NicOx).
Topics: Alzheimer Disease; Animals; Arthritis; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Flurbiprofen; Humans; Nitric Oxide Donors; Osteitis Deformans; Osteoporosis; Structure-Activity Relationship; Urinary Incontinence; Urticaria | 2004 |
Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Flurbiprofen; Humans; Inflammation; Microglia; Structure-Activity Relationship | 2005 |
[A novel class of anti-inflammatory and analgesic drugs--NO-donating NSAIDs].
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiotonic Agents; Cyclooxygenase Inhibitors; Flurbiprofen; Gastrointestinal Diseases; Humans; Ibuprofen; Naproxen; Nitrates; Nitric Oxide Donors | 2007 |
1 trial(s) available for nitroflurbiprofen and flurbiprofen
Article | Year |
---|---|
The effects and metabolic fate of nitroflurbiprofen in healthy volunteers.
Topics: Administration, Oral; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclooxygenase Inhibitors; Female; Flurbiprofen; Gastric Juice; Gastric Mucosa; Hemodynamics; Humans; Male; Nitric Oxide; Nitrogen Isotopes; Rats; Rats, Wistar; Stomach | 2004 |
52 other study(ies) available for nitroflurbiprofen and flurbiprofen
Article | Year |
---|---|
Inhibition of amyloidogenesis by nonsteroidal anti-inflammatory drugs and their hybrid nitrates.
Topics: Amyloid beta-Peptides; Amyloidosis; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Tumor; Humans; Mice; Neurons; Nitrates; Small Molecule Libraries | 2011 |
Flurbinitroxybutylester: a novel anti-inflammatory drug has enhanced antithrombotic activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Collagen; Drug Evaluation, Preclinical; Epinephrine; Fibrinolytic Agents; Flurbiprofen; Humans; Male; Mice; Molecular Structure; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Thromboembolism | 1995 |
Effect of a new non-steroidal anti-inflammatory drug, nitroflurbiprofen, on the expression of inducible nitric oxide synthase in rat neutrophils.
Topics: Administration, Oral; Amino Acid Oxidoreductases; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Separation; Centrifugation, Density Gradient; Enzyme Induction; Female; Flurbiprofen; Lipopolysaccharides; Neutrophils; Nitrates; Nitric Oxide Synthase; Nitrites; Rats; Rats, Sprague-Dawley | 1995 |
Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion; Flurbiprofen; Ketoprofen; Leukocytes; Male; Nitrates; Nitrites; Nitrogen Oxides; Platelet Aggregation; Prostaglandins; Rats; Rats, Wistar; Stomach Ulcer; Structure-Activity Relationship | 1994 |
Protective effect of NO on gastric lesions and inhibition of expression of gastric inducible NOS by flurbiprofen and its nitro-derivative, nitroflurbiprofen.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Female; Flurbiprofen; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stomach | 1995 |
Effects of flurbiprofen and flurbinitroxybutylester on prostaglandin endoperoxide synthases.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Cyclooxygenase Inhibitors; Dinoprostone; Drug Stability; Female; Flurbiprofen; Humans; Isoenzymes; Leukocytes, Mononuclear; Male; Middle Aged; Thromboxane B2 | 1996 |
Intestinal tolerability of nitroxybutyl-flurbiprofen in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Flurbiprofen; Intestine, Small; Male; Mitochondria, Liver; Oxidative Phosphorylation; Permeability; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 1997 |
Nitroflurbiprofen, a new nonsteroidal anti-inflammatory, ameliorates structural injury in the remnant kidney.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Flurbiprofen; Glomerulosclerosis, Focal Segmental; Hemodynamics; Kidney; Male; Nephrectomy; Nitric Oxide; Rats; Rats, Wistar | 1998 |
Radioprotective effects of flurbiprofen and its nitroderivative.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Cells; Flurbiprofen; Granulocytes; Leukocyte Count; Lymphocyte Count; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Radiation-Protective Agents; Spleen; Survival Analysis; Time Factors | 1998 |
Role of tumour necrosis factor-alpha and inducible nitric oxide synthase in the prevention of nitro-flurbiprofen small intestine toxicity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Flurbiprofen; Intestine, Small; Male; Nitric Oxide Synthase; Peroxidase; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Ulcer | 1998 |
Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Caspase Inhibitors; Cell Line; Cysteine Proteinase Inhibitors; DNA Fragmentation; Endothelium, Vascular; Flurbiprofen; Gastric Mucosa; Humans; In Situ Nick-End Labeling; Male; Mice; Naproxen; Nitric Oxide; Peroxidase; Rats; Rats, Wistar | 1999 |
Opposite effects of flurbiprofen and the nitroxybutyl ester of flurbiprofen on apoptosis in cultured guinea-pig gastric mucous cells.
Topics: Acid Phosphatase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase 3; Caspases; Cell Adhesion; Cell Extracts; Cells, Cultured; Ceramides; Cycloheximide; Dithiothreitol; Dose-Response Relationship, Drug; Enzyme Activation; Flurbiprofen; Gastric Mucosa; Guinea Pigs; Male; Nitric Oxide Donors; Penicillamine; Protein Synthesis Inhibitors; Proteins; Time Factors | 2000 |
Aortic hyporeactivity to norepinephrine induced by lipopolysaccharide in cirrhotic rats: beneficial effects of a non-steroidal anti-inflammatory drug coupled with a nitric oxide donor.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta, Thoracic; Flurbiprofen; Hemodynamics; Lipopolysaccharides; Liver Cirrhosis, Experimental; Male; Nitric Oxide Synthase; Norepinephrine; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 2001 |
Vasorelaxant effect of nitric oxide releasing steroidal and nonsteroidal anti-inflammatory drugs.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Aspirin; Blood Pressure; Dose-Response Relationship, Drug; Flurbiprofen; In Vitro Techniques; Kidney; Male; Mesentery; Nitric Oxide; Nitroprusside; Prednisolone; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents | 2001 |
Palladium-catalyzed alpha-arylation of esters.
Topics: Acetates; Anti-Inflammatory Agents, Non-Steroidal; Bromides; Catalysis; Esters; Flurbiprofen; Lithium; Molecular Structure; Naproxen; Organosilicon Compounds; Palladium; Phosphines | 2001 |
Inhibition of bone resorption in vitro and prevention of ovariectomy-induced bone loss in vivo by flurbiprofen nitroxybutylester (HCT1026).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Resorption; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Female; Flurbiprofen; In Vitro Techniques; Mice; Mice, Inbred C57BL; Osteoblasts; Osteoclasts; Ovariectomy; Spleen | 2001 |
Differential effects of the nonsteroidal antiinflammatory drug flurbiprofen and its nitric oxide-releasing derivative, nitroflurbiprofen, on prostaglandin E(2), interleukin-1beta, and nitric oxide synthesis by activated microglia.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Brain; Cell Survival; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Drug; Down-Regulation; Encephalitis; Flurbiprofen; Interleukin-1; Lipopolysaccharides; Macrophages; Microglia; Neurodegenerative Diseases; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitrites; Nitroso Compounds; Prostaglandin-Endoperoxide Synthases; Rats | 2001 |
Beneficial effects of NO-releasing derivative of flurbiprofen (HCT-1026) in rat model of vascular injury and restenosis.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carotid Arteries; Coronary Restenosis; Dose-Response Relationship, Drug; Flurbiprofen; Hyperplasia; Immunohistochemistry; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Stomach Diseases; Tunica Intima | 2002 |
Metabolic profile of NO-flurbiprofen (HCT1026) in rat brain and plasma: a LC-MS study.
Topics: Administration, Oral; Animals; Blood; Brain; Chromatography, High Pressure Liquid; Flurbiprofen; Male; Mass Spectrometry; Rats; Rats, Inbred F344; Reproducibility of Results | 2002 |
Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: Shifting the angiogenic balance.
Topics: Animals; Apoptosis; Cell Division; Cells, Cultured; Collagen; Cyclooxygenase Inhibitors; Endostatins; Endothelial Growth Factors; Flurbiprofen; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Neovascularization, Pathologic; Nitric Oxide; Peptide Fragments; Rats; Rats, Wistar; Stomach; Thrombin; Time Factors; Ulcer; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Brain; Cholinesterase Inhibitors; Dentate Gyrus; Drug Therapy, Combination; Encephalitis; Flurbiprofen; Galantamine; Immunohistochemistry; Male; Microglia; Nitric Oxide Donors; Radioligand Assay; Rats; Rats, Inbred F344 | 2002 |
The influence of brain inflammation upon neuronal adenosine A2B receptors.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Disease Models, Animal; Encephalitis; Flurbiprofen; Immunohistochemistry; Lipopolysaccharides; Male; Microglia; Neurons; Nitric Oxide Donors; Rats; Rats, Inbred F344; Receptor, Adenosine A2B; Receptors, Purinergic P1; Second Messenger Systems | 2003 |
Addition of nitric oxide via nitroflurbiprofen enhances the material properties of early healing of young rat Achilles tendons.
Topics: Achilles Tendon; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomechanical Phenomena; Body Water; Collagen; Coloring Agents; Extracellular Space; Flurbiprofen; Male; Nitric Oxide; Organ Size; Rats; Rats, Sprague-Dawley; Weight Gain; Wound Healing | 2003 |
Effect of nitric oxide releasing paracetamol and flurbiprofen on cytokine production in human blood.
Topics: Acetaminophen; Cytokines; Flurbiprofen; Free Radical Scavengers; Humans; Nitrates; Nitric Oxide Donors | 2004 |
Placing bets. National Institute on Aging committee chooses three compounds for definitive longevity testing.
Topics: Aging; Animals; Aspirin; Flurbiprofen; Longevity; Mice; National Institutes of Health (U.S.); United States | 2004 |
Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cyclooxygenase 2; Drug Therapy, Combination; Flurbiprofen; Hypertension, Renal; Immunohistochemistry; Isoenzymes; Kidney; Kidney Diseases; Losartan; Male; Nephrectomy; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1 | 2004 |
A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis.
Topics: Administration, Oral; Adoptive Transfer; Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; CD4-Positive T-Lymphocytes; Cell Movement; Central Nervous System; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Epitopes, T-Lymphocyte; Female; Flurbiprofen; Glycoproteins; Growth Inhibitors; Immunosuppressive Agents; Interleukin-10; Lectins, C-Type; Lymphocyte Count; Mice; Mice, Inbred C57BL; Mice, Knockout; Myelin-Oligodendrocyte Glycoprotein; Nitric Oxide; Peptide Fragments; Receptors, Interleukin-2; RNA, Messenger; Spleen; T-Lymphocyte Subsets | 2004 |
The influence on human osteoblasts in vitro of non-steroidal anti-inflammatory drugs which act on different cyclooxygenase enzymes.
Topics: Acetaminophen; Alkaline Phosphatase; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Count; Cells, Cultured; Collagen; Cyclooxygenase Inhibitors; DNA; Flurbiprofen; Furans; Humans; Indomethacin; Nitrates; Nitric Oxide; Nitric Oxide Donors; Osteoblasts; Prostaglandin-Endoperoxide Synthases | 2004 |
The flurbiprofen derivatives HCT1026 and HCT1027 inhibit bone resorption by a mechanism independent of COX inhibition and nitric oxide production.
Topics: Animals; Bone Resorption; Cells, Cultured; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Flurbiprofen; Humans; Mice; Nitric Oxide; Prostaglandin-Endoperoxide Synthases; Rabbits | 2004 |
NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Cells, Cultured; Cyclic AMP; Cyclic GMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Flurbiprofen; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Indomethacin; Membrane Proteins; Naproxen; Nitric Oxide Donors; Nitroprusside; Phosphodiesterase Inhibitors; Prostaglandin-Endoperoxide Synthases; Purinones; Synovial Membrane; Time Factors | 2005 |
Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cerebral Cortex; Flurbiprofen; Microglia; PPAR gamma; Rats; Rats, Wistar | 2005 |
Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.
Topics: Acetylcholinesterase; Age Factors; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Butyrylcholinesterase; CD11b Antigen; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogens; Flurbiprofen; Fornix, Brain; Glial Fibrillary Acidic Protein; Hippocampus; Histocytochemistry; Inflammation; Male; Membrane Transport Proteins; Mice; Mice, Transgenic; Oligopeptides; Ovariectomy; Random Allocation; Vesicular Acetylcholine Transport Proteins | 2005 |
Flurbiprofen and HCT1026 protect mice against acute pancreatitis-associated lung injury.
Topics: Acute Disease; Amylases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Flurbiprofen; Gastric Mucosa; Inflammation; Lung; Lung Injury; Male; Mice; Neutrophils; Nitric Oxide; Pancreas; Pancreatitis; Peroxidase; Sepsis; Time Factors | 2005 |
In vitro metabolism of (nitrooxy)butyl ester nitric oxide-releasing compounds: comparison with glyceryl trinitrate.
Topics: Animals; Biotransformation; Butanes; Cytosol; Flurbiprofen; In Vitro Techniques; Liver; Male; Mitochondria, Liver; Molecular Structure; Nitric Oxide; Nitric Oxide Donors; Nitro Compounds; Rats; Rats, Sprague-Dawley | 2006 |
Nitric oxide-releasing flurbiprofen reduces formation of proinflammatory hydrogen sulfide in lipopolysaccharide-treated rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cystathionine gamma-Lyase; Flurbiprofen; Hydrogen Sulfide; Interleukin-1beta; Kidney; Lipopolysaccharides; Liver; Male; Nitric Oxide; Rats; Rats, Sprague-Dawley; Shock, Septic; Tumor Necrosis Factor-alpha | 2006 |
Flurbiprofen and its nitric oxide-releasing derivative protect against septic shock in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cecum; Disease Models, Animal; Flurbiprofen; Interleukin-1beta; Ligation; Male; Nitrates; Nitric Oxide; Nitrites; Rats; Rats, Sprague-Dawley; Shock, Septic; Tumor Necrosis Factor-alpha | 2006 |
Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Combined Modality Therapy; Creatine Kinase; Flurbiprofen; Mice; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Nitric Oxide Donors; Prednisolone; Regeneration; Sarcoglycans; Stem Cell Transplantation | 2007 |
Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Topics: Animals; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Flurbiprofen; Hypertension, Portal; Kidney Diseases; Liver; Liver Circulation; Liver Cirrhosis, Experimental; Male; Nitric Oxide; Nitric Oxide Donors; Peptic Ulcer; Perfusion; Portal Pressure; Rats; Rats, Wistar; Thioacetamide; Thromboxane A2; Vascular Resistance; Vasoconstriction; Vasodilation | 2007 |
Binary polymeric blends to microencapsulate nitroflurbiprofen: physicochemical and in silico studies.
Topics: Acrylates; Algorithms; Calorimetry, Differential Scanning; Cyclooxygenase Inhibitors; Drug Carriers; Drug Compounding; Flurbiprofen; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Monte Carlo Method; Particle Size; Polymers; Povidone; Spectroscopy, Fourier Transform Infrared; Thermodynamics; Transition Temperature; Viscosity; Water | 2007 |
An Aging Interventions Testing Program: study design and interim report.
Topics: Aging; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Cyclic N-Oxides; Drug Evaluation, Preclinical; Female; Flurbiprofen; Male; Masoprocol; Mice; Research Design; Survival Analysis | 2007 |
Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice.
Topics: Animals; Aspirin; Cyclic N-Oxides; Cyclooxygenase Inhibitors; Female; Flurbiprofen; Free Radical Scavengers; Genetic Heterogeneity; Lipoxygenase Inhibitors; Longevity; Male; Masoprocol; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Random Allocation; Sex Characteristics; Survival Analysis | 2008 |
The nitrosylated flurbiprofen derivative HCT1026 inhibits cytokine-induced signalling through a novel mechanism of action.
Topics: Actins; Animals; Apoptosis; Bone Resorption; Cytokines; Enzyme Activation; Flurbiprofen; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; Nitroso Compounds; Osteoclasts; RANK Ligand; Signal Transduction | 2009 |
[In vitro effects of a novel class of nitric oxide donating compounds on isolated human urinary bladder].
Topics: Anti-Infective Agents; Cyclic GMP; Flurbiprofen; Humans; In Vitro Techniques; Muscle, Smooth; Nitric Oxide; Urinary Bladder, Overactive | 2009 |
NO-flurbiprofen reduces amyloid-beta, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Avoidance Learning; Cell Line, Tumor; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flurbiprofen; Humans; Immunoprecipitation; Lipopolysaccharides; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroblastoma; Neuroprotective Agents; Nitric Oxide Synthase Type II; Peptide Fragments; Prostaglandins; Rats; Rats, Long-Evans; Scopolamine; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tetrazolium Salts; Thiazoles; Transfection | 2009 |
Selective modulation of amyloid-beta peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Abeta levels.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cell Line, Tumor; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Fenofibrate; Flurbiprofen; Humans; Immunoprecipitation; Mice; Neuroblastoma; Peptide Fragments; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Transfection | 2009 |
Life extension by diet restriction and N-acetyl-L-cysteine in genetically heterogeneous mice.
Topics: Acetylcysteine; Animals; Aspirin; Crosses, Genetic; Diet; Female; Flurbiprofen; Imines; Life Expectancy; Longevity; Male; Masoprocol; Mice; Mice, Inbred Strains; Phenols; Sex Factors | 2010 |
Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Flurbiprofen; Humans; Inflammation; Macrophage-1 Antigen; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidoreductases; Parkinson Disease; Rotarod Performance Test; Substantia Nigra; Tyrosine | 2010 |
Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Differentiation; CD11b Antigen; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Female; Flurbiprofen; Glial Fibrillary Acidic Protein; Hippocampus; Humans; Leukocyte Common Antigens; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Presenilin-1 | 2011 |
Switching the microglial harmful phenotype promotes lifelong restoration of subtantia nigra dopaminergic neurons from inflammatory neurodegeneration in aged mice.
Topics: Aging; Animals; Dopaminergic Neurons; Flurbiprofen; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Nerve Degeneration; Nerve Regeneration; Nitrosation; Oxidative Stress; Phenotype; Real-Time Polymerase Chain Reaction; RNA, Messenger; Substantia Nigra; Tyrosine 3-Monooxygenase | 2011 |
miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Colonic Neoplasms; Flurbiprofen; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mice; MicroRNAs; Receptor, IGF Type 1 | 2012 |
Treatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomechanical Phenomena; Disease Models, Animal; Feeding Behavior; Flurbiprofen; Hemodynamics; Hindlimb; Ischemia; Male; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscles; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Nitric Oxide Donors; Norepinephrine; Time Factors; Vasoconstriction; Weight Gain | 2012 |
Metabolism and pathways for denitration of organic nitrates in the human liver.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Butanes; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytosol; Enzyme Inhibitors; Female; Flurbiprofen; Free Radical Scavengers; Humans; Kinetics; Liver; Male; Metabolic Detoxication, Phase I; Microsomes, Liver; Mitochondria, Liver; Nitric Oxide; Nitro Compounds; Nitroglycerin; Vasodilator Agents | 2013 |